APA (7th ed.) Citation

E, P., F, A., R, B., M, D., NM, D., D, S., . . . D, S. (2026). BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford, England), 65(7), . https://doi.org/10.1093/rheumatology/keag345

Chicago Style (17th ed.) Citation

E, Phithak, et al. "BCMA-directed Therapy with Cizutamig Induces Rapid Improvement in Long-standing Systemic Sclerosis-associated Interstitial Lung Disease." Rheumatology (Oxford, England) 65, no. 7 (2026). https://doi.org/10.1093/rheumatology/keag345.

MLA (9th ed.) Citation

E, Phithak, et al. "BCMA-directed Therapy with Cizutamig Induces Rapid Improvement in Long-standing Systemic Sclerosis-associated Interstitial Lung Disease." Rheumatology (Oxford, England), vol. 65, no. 7, 2026, https://doi.org/10.1093/rheumatology/keag345.